About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Brain Imaging, Nutrition, and Cognition in Breast Cancer Survivors

NCT05122000·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Ohio State University

Age

45–75

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Stage I-III breast cancer diagnosis
Between 3-12 months post-treatment with anthracycline or taxane-based chemotherapy
Postmenopausal (at least 12 months without menses; OR on ovarian suppression medication; OR status post oophorectomy)
English speaking

You may not be if

Women who have permanent ferromagnetic metal in the body, a pacemaker, or have severe claustrophobia
Women who are pregnant or breastfeeding
Diagnosis of dementia, psychosis, alcohol or substance use disorders
Concurrent other malignancy or metastatic malignancy of any kind
Unable to give informed consent.

The record

StatusCompleted

PhaseNo phase

Taking part30

StartedJan 2022

UpdatedMay 14, 2025

Conditions

Where1

The Ohio State University
Columbus, Ohio, United States

Clareo Health | Brain Imaging, Nutrition, and Cognition in Breast Cancer Survivors